Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melinda Mata

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 1, 2016
Man's Best Friend: Utilizing Naturally Occurring Tumors in Dogs to Improve Chimeric Antigen Receptor T-cell Therapy for Human CancersMelinda Mata, Stephen Gottschalk
Immunotherapy|January 10, 2015
Adoptive cell therapy for sarcomaMelinda Mata, Stephen Gottschalk
Drugs|February 24, 2019
Engineering for Success: Approaches to Improve Chimeric Antigen Receptor T Cell Therapy for Solid TumorsMelinda Mata, Stephen Gottschalk
Cancer Discovery|August 13, 2017
Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor ModelsMelinda Mata, Claudia Gerken, Phuong Nguyen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 9, 2014
Toward immunotherapy with redirected T cells in a large animal model: ex vivo activation, expansion, and genetic modification of canine T cellsMelinda Mata, Juan F Vera, Claudia Gerken, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2013
Antitumor effects of chimeric receptor engineered human T cells directed to tumor stromaSunitha Kakarla, Kevin K H Chow, Melinda Mata, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 1, 2016
Man's Best Friend: Utilizing Naturally Occurring Tumors in Dogs to Improve Chimeric Antigen Receptor T-cell Therapy for Human CancersMelinda Mata, Stephen Gottschalk
Immunotherapy|January 10, 2015
Adoptive cell therapy for sarcomaMelinda Mata, Stephen Gottschalk
Drugs|February 24, 2019
Engineering for Success: Approaches to Improve Chimeric Antigen Receptor T Cell Therapy for Solid TumorsMelinda Mata, Stephen Gottschalk
Cancer Discovery|August 13, 2017
Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor ModelsMelinda Mata, Claudia Gerken, Phuong Nguyen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 9, 2014
Toward immunotherapy with redirected T cells in a large animal model: ex vivo activation, expansion, and genetic modification of canine T cellsMelinda Mata, Juan F Vera, Claudia Gerken, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2013
Antitumor effects of chimeric receptor engineered human T cells directed to tumor stromaSunitha Kakarla, Kevin K H Chow, Melinda Mata, et al.
Pageof 1